Lobbying client · LD-2 disclosures
Rocket Pharmaceuticals, Inc.
New Jersey
19 filings from 3 registrants · 2019–2026 · latest filed Jul 19, 2026
Reported on its behalf
$330K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$330K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
6 filings
$50K on those filings
Immigration
IMM
4 filings
$110K on those filings
Pharmacy
PHA
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- Toby Moffett Mercury Public Affairs, LLC7 filingsthrough 2022
- Anthony J Moffett Mayer Brown LLP5 filingsthrough 2020
- Jacob Jackson The Kpm Group DC LLC2 filingsthrough 2024
- Paula Gutierrez The Kpm Group DC LLC2 filingsthrough 2024
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: rocket-pharmaceuticals-inc.